234 related articles for article (PubMed ID: 15140972)
1. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity.
Campbell EM; Nunez R; Hope TJ
J Virol; 2004 Jun; 78(11):5745-55. PubMed ID: 15140972
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
[TBL] [Abstract][Full Text] [Related]
3. Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.
Khan M; Garcia-Barrio M; Powell MD
J Virol; 2001 Dec; 75(24):12081-7. PubMed ID: 11711598
[TBL] [Abstract][Full Text] [Related]
4. Nef does not inhibit F-actin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse.
Haller C; Tibroni N; Rudolph JM; Grosse R; Fackler OT
Eur J Cell Biol; 2011 Nov; 90(11):913-21. PubMed ID: 21044805
[TBL] [Abstract][Full Text] [Related]
5. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
Aiken C; Trono D
J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
[TBL] [Abstract][Full Text] [Related]
6. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.
Zhou J; Aiken C
J Virol; 2001 Jul; 75(13):5851-9. PubMed ID: 11390586
[TBL] [Abstract][Full Text] [Related]
7. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.
Venzke S; Michel N; Allespach I; Fackler OT; Keppler OT
J Virol; 2006 Nov; 80(22):11141-52. PubMed ID: 16928758
[TBL] [Abstract][Full Text] [Related]
8. Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.
Khan M; Jin L; Huang MB; Miles L; Bond VC; Powell MD
J Virol; 2004 Feb; 78(4):1843-50. PubMed ID: 14747548
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity.
Aiken C
Virology; 1998 Aug; 248(1):139-47. PubMed ID: 9705263
[TBL] [Abstract][Full Text] [Related]
10. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
[TBL] [Abstract][Full Text] [Related]
11. Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity.
Fackler OT; d'Aloja P; Baur AS; Federico M; Peterlin BM
J Virol; 2001 Jul; 75(14):6601-8. PubMed ID: 11413327
[TBL] [Abstract][Full Text] [Related]
12. Cell-dependent functional roles of HIV-1 Nef for virus replication (review).
Adachi A; Oshima Y
Int J Mol Med; 1999 Apr; 3(4):427-30. PubMed ID: 10085418
[TBL] [Abstract][Full Text] [Related]
13. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems.
Luo T; Douglas JL; Livingston RL; Garcia JV
Virology; 1998 Feb; 241(2):224-33. PubMed ID: 9499797
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent.
Tokunaga K; Kojima A; Kurata T; Ikuta K; Akari H; Koyama AH; Kawamura M; Inubushi R; Shimano R; Adachi A
J Gen Virol; 1998 Oct; 79 ( Pt 10)():2447-53. PubMed ID: 9780050
[TBL] [Abstract][Full Text] [Related]
15. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.
Aiken C
J Virol; 1997 Aug; 71(8):5871-7. PubMed ID: 9223476
[TBL] [Abstract][Full Text] [Related]
16. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.
Pizzato M; Helander A; Popova E; Calistri A; Zamborlini A; Palù G; Göttlinger HG
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6812-7. PubMed ID: 17412836
[TBL] [Abstract][Full Text] [Related]
17. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.
Lundquist CA; Zhou J; Aiken C
J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.
Cavrois M; Neidleman J; Yonemoto W; Fenard D; Greene WC
Virology; 2004 Oct; 328(1):36-44. PubMed ID: 15380356
[TBL] [Abstract][Full Text] [Related]
19. Nef enhances HIV-1 infectivity via association with the virus assembly complex.
Qi M; Aiken C
Virology; 2008 Apr; 373(2):287-97. PubMed ID: 18191978
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
Schaeffer E; Geleziunas R; Greene WC
J Virol; 2001 Mar; 75(6):2993-3000. PubMed ID: 11222724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
